Every year the Clarivate Analytics publishes a list of world class researchers selected for an exceptional research performance in their respective fields. The list uses data from “Web of Science” and features researchers that published multiple highly cited papers that rank in the top 1% by citations.
Prof. Dr. Sibylle Loibl, CEO of the GBG Forschungs GmbH and Professor at the Goethe University Frankfurt is featured among these researchers in 2018 for her work in breast cancer research. The publication of state of the art research results and study outcomes on the highest academic level represents a central objective for the German Breast Group in improving breast cancer therapy for patients.
As Germany´s largest Breast Cancer study group, GBG combines latest pharmaceutical drugs and innovative study designs and focuses with its research on neoadjuvant, adjuvant, surgical and palliative therapy.